Adjuvant HD Cisplatin-RT For High Risk Head & Neck Cancer
May 05, 2022•17 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Landmarks of OncoPharm series returns to discuss 2 landmark studies (and 1 editorial) in head & neck cancer.
Editorial: https://ascopubs.org/doi/pdf/10.1200/JCO.22.00274
EUORTC Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032641
Intergroup Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032646
For the best experience, listen in Metacast app for iOS or Android